DF/HCC Myeloid Malignancies SPORE - CEP & DRP RFAs

October 17, 2017

DF/HCC's Newest SPORE - the Myeloid Malignancies SPORE - has released RFA's for its Career Enhancement and Developmental Research Project Awards, with applications due on December 1, 2017. Read more about these awards below for more information.

Career Enhancement Program RFA

The Leukemia Program at the Dana-Farber/Harvard Cancer Center (DF/HCC) is seeking applications for Career Enhancement Program (CEP) projects focused on adult or pediatric myeloid malignancies. Funding will be provided for up to two awards through the National Cancer Institute (NCI)-sponsored Specialized Program of Research Excellence (SPORE) mechanism. 

REQUEST FOR APPLICATIONS: Career Enhancement Awards in Myeloid Malignancies
AWARD AMOUNT: Up to $50,000 (direct costs) for 1 year with a chance for renewal contingent on progress and available funds.
APPLICATION DEADLINE: On or before 5pm on Friday, December 1, 2017

The Leukemia Program at the Dana-Farber/Harvard Cancer Center (DF/HCC) is seeking applications for Career Enhancement Program (CEP) projects focused on adult or pediatric myeloid malignancies. Funding will be provided for up to two awards through the National Cancer Institute (NCI)-sponsored Specialized Program of Research Excellence (SPORE) mechanism.  

The goal of the CEP is to recruit and train new investigators in the field of translational leukemia research. Eligible candidates include Junior Faculty (Instructor or Assistant Professor) without R01 or equivalent grants or senior post-doctoral fellows (PhD, MD, or MD-PhD) who have a written commitment from their department chair confirming plans for promotion to a faculty position within one year. Applicants must identify mentors (basic and clinical), provide a career development plan (may include didactic training), and propose a translational project (clinical or laboratory-based) with a human endpoint. Applications will be judged on: 1) the candidate’s academic track record, 2) the scientific merit of the research plan, 3) the likelihood that the proposed plan of mentored research and training will enhance the applicant’s development towards a career in independent translational leukemia research.

Application deadline is December 1, 2017.  Up to two awards of $50,000 will be made for the funding period from January 1, 2018 through December 31, 2018. A second year of funding is contingent upon adequate progress and available funds. Funds can be used for the applicants’ salary/fringe (up to 50% effort), research materials, travel, and didactic training at any DF/HCC-affiliated institution. 

An application consists of the following components:

  • Research Plan (6 pages maximum)
  • Career Development Plan (1 page)
  • Mentor Letters of Support
  • Budget & Justification, Other Support, Biosketch

Minority and women applicants are strongly encouraged to apply. Additional information may be obtained by contacting the Administrative Coordinator, Daniel Blackwell (danielb@broadinstitute.org), or by going to the SPORE website at http://www.dfhcc.harvard.edu/MyeloidSPORE

Hide

Developmental Research Project RFA

The Dana-Farber/Harvard Cancer Center Specialized Program in Research Excellence (SPORE) seeks applications for Developmental Research Project Awards in Myeloid Malignancies. The objective of the Developmental Research Program is to identify and fund new ideas and projects for the SPORE in Myeloid Malignancies.

REQUEST FOR APPLICATIONS: Developmental Research Project Awards in Myeloid Malignancies
AWARD AMOUNT: Approximately $50,000 in annual direct costs
APPLICATION DEADLINE: On or before 5pm on Friday, December 1, 2017


Download full RFA here

The Dana-Farber/Harvard Cancer Center Specialized Program in Research Excellence (SPORE) seeks applications for Developmental Research Project Awards in Myeloid Malignancies.  The objective of the Developmental Research Program is to identify and fund new ideas and projects for the SPORE in Myeloid Malignancies. 

Applicants must be on the faculty at Harvard Medical School or the Harvard T.H. Chan School of Public Health at the level of Instructor or higher. A track record of interest and productivity in leukemia or hematologic malignancy research is strongly desired. The research plan and career goals of the individual may include the disciplines of basic biology, translational science, clinical science, population studies, outcomes, or social science but must have a plan for translation into humans, since the purpose of the this program is to promote translational research in Myeloid Malignancies. Applications will be judged on their merit and/or their potential contribution to the overall status of the DF/HCC SPORE in Myeloid Malignancies.

The awardees will receive one year of funding which can be used for salary and/or support of research at Harvard Medical School, the Harvard School of Public Health or any of the Harvard-affiliated hospitals. Awardees will be expected to attend SPORE activities (meetings, retreats, research presentations). Women and minority candidates are strongly encouraged to apply. We anticipate awarding 2 awards in the approximate amount of $50,000 in annual direct costs.

Please forward a single PDF file containing all materials to Daniel Blackwell (email: DBlackwell@bwh.harvard.edu) by 5 PM Friday, December 1, 2017.  Please cc: Dr. Benjamin Ebert (Benjamin_Ebert@dfci.harvard.edu) and Richard Stone (Richard_Stone@dfci.harvare.edu) with your submission.

Applications should consist of the following:

  1. A brief summary of the research plan (not to exceed 5 pages excluding references) including an Abstract, Specific Aims, Background and Relevance, Preliminary Data, Experimental Methods/Research Plan, Translational Goals, and anticipated time line.
  2. Budget with justification
  3. Applicant’s biosketch (NIH Format)
Hide